ARNA Breast
Early-stage Breast Cancer Detection
Development/Clinical TrialsActive
Key Facts
Indication
Early-stage Breast Cancer Detection
Phase
Development/Clinical Trials
Status
Active
Company
About ARNA Genomics
ARNA Genomics is a private, pre-revenue diagnostics company developing a proprietary liquid biopsy platform for early cancer detection. Its lead program, ARNA Breast, is an assay for early-stage breast cancer currently in development and clinical trials. The company boasts a scientifically distinguished leadership team, including inventor Anatoly Melnikov and renowned scientist Dr. Charles R. Cantor, and is headquartered in Orange County, California.
View full company profile